Why most T-cell engagers fail - and how to fix it - Drug Target Review

Retrieved on: 2025-08-08 12:11:22

Tags for this article:

Click the tags to see associated articles and topics

Why most T-cell engagers fail - and how to fix it - Drug Target Review. View article details on hiswai:

Excerpt

While monoclonal antibodies and antibody-drug conjugates continue to drive therapeutic pipelines, bispecific T-cell engagers (TCEs) are gaining ...

Article found on: www.drugtargetreview.com